£270k
+13%vs Jun 2024Active12146324Private limited companyLondon
GLOBOCEUTICS LTD
Significant control: Pinky Nikunjkumar Patel (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Globoceutics Ltd sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GLOBOCEUTICS LTD is an active private limited company (company number 12146324) incorporated on 8 August 2019, registered in London. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest abridged accounts cover the period ending 30 June 2025, showing net assets of £270k and cash of £1,354, with 3 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 13% on the prior period (£239k).
Peer position · net assets
By net assets it sits in the top quarter of 435 comparable companies in London (median £2,000, upper quartile £90k).
02
Ownership and control
- Mrs Pinky Nikunjkumar Patel
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Mr Niral Jayesh Desai
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 8 August 20197 yrs ago
- Next accounts due
- 30 March 2027in 158 days
- Confirmation statement due
- 22 August 2027in 303 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
05
Financials
£1,354
−38%vs Jun 2024Not disclosed
3
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £270k | £1,354 | £79k | £170k | — | — | 3 |
| 30 June 2024 | £239k | £2,193 | £38k | £247k | — | — | 3 |
Current ratio0.47Current assets ÷ creditors within one year
Cash per employee£451Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £269,515 at 30 June 2025
- Net assets up 10% or more on the prior period+12.8% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.47
- Incorporated five or more years agoIncorporated 8 August 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 303 days
- Next accounts duein 158 days
- Accounts period endNet assets £270k · abridged accounts
- Accounts period endNet assets £239k · abridged accounts
- Incorporated
08
Similar companies in London
- MAXX PHARM LTDLondon · inc. Jul 2019
- SOTERIA HOLDINGS LTDLondon · inc. Jul 2019
- NOVACELL UK LIMITEDLondon · inc. Jul 2019
- LAKES CARE GROUP LTDLondon · inc. Sept 2019
- MAX GENES LTDLondon · inc. Sept 2019
- CHESTERFIELD PHARMA LTDLondon · inc. Jun 2019
All companies incorporated on 8 August 2019 · in Aug 2019.
09
Reminders for GLOBOCEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.